Tylenol (Cotylenol)


Combined with:

Rebif

Indications and Reactions:

Role Indications Reactions
Secondary
Multiple Sclerosis 50.0%
Premedication 50.0%
Hepatic Enzyme Increased 66.7%
Vomiting 33.3%
Concomitant
Multiple Sclerosis 84.3%
Acute Myeloid Leukaemia 4.5%
Relapsing-remitting Multiple Sclerosis 3.0%
Localised Infection 1.5%
Off Label Use 1.1%
Fatigue 0.7%
Herpes Zoster 0.7%
Prostate Cancer Metastatic 0.7%
Sepsis 0.7%
Depression 0.4%
Hormone Replacement Therapy 0.4%
Myalgia 0.4%
Pain 0.4%
Product Used For Unknown Indication 0.4%
Rheumatoid Arthritis 0.4%
Sleep Disorder 0.4%
Urinary Tract Infection 13.6%
Vomiting 8.0%
Diabetes Mellitus 5.7%
Multiple Sclerosis 5.7%
Nausea 5.7%
Respiratory Arrest 5.7%
Convulsion 4.5%
Multiple Sclerosis Relapse 4.5%
Stomatitis 4.5%
Thrombosis 4.5%
Vision Blurred 4.5%
Weight Decreased 4.5%
White Blood Cell Count Decreased 4.5%
Cholelithiasis 3.4%
Diverticulitis 3.4%
Hypoaesthesia 3.4%
Infection 3.4%
Metastases To Lymph Nodes 3.4%
Pancreatitis 3.4%
Rectal Haemorrhage 3.4%

Drug Data